CorMedix (CRMD) Stock: Why It's Up Today
Updated Oct 19, 2026, 12:35 PM ET · intraday price
- Trading at $7.49 as of 12:35 PM ET, +3.17% vs the prior close of $7.26.
- Volume 472.32K shares, 0.4x its 50-day average (light).
- New SEC filings: 8-K (Oct 19, 2026).
- No new insider buys or sales reported since the prior session.
CRMD jumps 3.2% to $7.49. Trading at $7.49 (intraday, 12:35 PM ET), +3.17% vs the prior close of $7.26. Day range $7.25–$7.57, opened at $7.26.
CRMD daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — CRMD jumps 3.2% to $7.49
- Trading at $7.49 (intraday, 12:35 PM ET), +3.17% vs the prior close of $7.26. Day range $7.25–$7.57, opened at $7.26.
- Volume was 472.32K shares, 0.4x its 50-day average of 1.17M — lighter than usual.
- Price is -4.3% vs its 50-day average ($7.83) and -3.3% vs its 200-day average ($7.75).
- 52-week range $6.13–$13.02; the current price sits at 20% of that range, 42.5% below the 52-week high.
- SEC filings that day: 8-K.
Oct 16, 2026 — CRMD dips 2.7% to $7.26
- Closed at $7.26, -2.68% vs the prior close of $7.46. Day range $7.24–$7.44, opened at $7.44.
- Volume was 1.14M shares, 1.0x its 50-day average of 1.16M.
- Price is -7.3% vs its 50-day average ($7.83) and -6.5% vs its 200-day average ($7.77).
- 52-week range $6.13–$13.02; today's close sits at 16% of that range, 44.2% below the 52-week high.
Oct 15, 2026 — CRMD rises 0.9% to $7.46
- Closed at $7.46, +0.95% vs the prior close of $7.39. Day range $7.43–$7.70, opened at $7.49.
- Volume was 1.47M shares, 1.3x its 50-day average of 1.14M.
- Price is -4.8% vs its 50-day average ($7.83) and -4.3% vs its 200-day average ($7.79).
- 52-week range $6.13–$13.02; today's close sits at 19% of that range, 42.7% below the 52-week high.
Oct 14, 2026 — CRMD ends flat (+0.0%) to $7.39
- Closed at $7.39, +0.00% vs the prior close of $7.39. Day range $7.27–$7.53, opened at $7.36.
- Volume was 1.12M shares, 1.0x its 50-day average of 1.13M.
- Price is -5.6% vs its 50-day average ($7.83) and -5.5% vs its 200-day average ($7.82).
- 52-week range $6.13–$13.02; today's close sits at 18% of that range, 43.2% below the 52-week high.
Oct 13, 2026 — CRMD dips 0.9% to $7.39
- Closed at $7.39, -0.94% vs the prior close of $7.46. Day range $7.33–$7.55, opened at $7.43.
- Volume was 1.42M shares, 1.3x its 50-day average of 1.12M.
- Price is -5.7% vs its 50-day average ($7.83) and -5.8% vs its 200-day average ($7.84).
- 52-week range $6.13–$13.02; today's close sits at 18% of that range, 43.2% below the 52-week high.
Oct 12, 2026 — CRMD rises 1.1% to $7.46, 3 up days in a row
- Closed at $7.46, +1.08% vs the prior close of $7.38. Day range $7.16–$7.60, opened at $7.41.
- Volume was 1.59M shares, 1.4x its 50-day average of 1.10M.
- Price is -4.8% vs its 50-day average ($7.84) and -5.2% vs its 200-day average ($7.87).
- 52-week range $6.13–$13.02; today's close sits at 19% of that range, 42.7% below the 52-week high.
- That makes 3 straight gains.
Oct 9, 2026 — CRMD rises 0.8% to $7.38
- Closed at $7.38, +0.82% vs the prior close of $7.32. Day range $7.26–$7.46, opened at $7.32.
- Volume was 1.19M shares, 1.1x its 50-day average of 1.10M.
- Price is -5.9% vs its 50-day average ($7.84) and -6.5% vs its 200-day average ($7.89).
- 52-week range $6.13–$13.02; today's close sits at 18% of that range, 43.3% below the 52-week high.
Oct 8, 2026 — CRMD rises 0.5% to $7.32
- Closed at $7.32, +0.55% vs the prior close of $7.28. Day range $7.18–$7.36, opened at $7.28.
- Volume was 1.02M shares, 0.9x its 50-day average of 1.11M.
- Price is -6.6% vs its 50-day average ($7.84) and -7.5% vs its 200-day average ($7.92).
- 52-week range $6.13–$13.02; today's close sits at 17% of that range, 43.8% below the 52-week high.
Oct 7, 2026 — CRMD ends flat (+0.0%) to $7.28
- Closed at $7.28, +0.00% vs the prior close of $7.28. Day range $7.18–$7.31, opened at $7.27.
- Volume was 833.00K shares, 0.7x its 50-day average of 1.12M.
- Price is -7.1% vs its 50-day average ($7.84) and -8.3% vs its 200-day average ($7.94).
- 52-week range $6.13–$13.02; today's close sits at 17% of that range, 44.1% below the 52-week high.
Oct 6, 2026 — CRMD ends flat (+0.3%) to $7.28
- Closed at $7.28, +0.28% vs the prior close of $7.26. Day range $7.13–$7.40, opened at $7.38.
- Volume was 744.30K shares, 0.7x its 50-day average of 1.13M.
- Price is -7.1% vs its 50-day average ($7.84) and -8.6% vs its 200-day average ($7.96).
- 52-week range $6.13–$13.02; today's close sits at 17% of that range, 44.1% below the 52-week high.
Oct 5, 2026 — CRMD rises 1.0% to $7.26
- Closed at $7.26, +0.97% vs the prior close of $7.19. Day range $7.06–$7.33, opened at $7.18.
- Volume was 1.26M shares, 1.1x its 50-day average of 1.12M.
- Price is -7.5% vs its 50-day average ($7.85) and -9.1% vs its 200-day average ($7.98).
- 52-week range $6.13–$13.02; today's close sits at 16% of that range, 44.2% below the 52-week high.
Oct 2, 2026 — CRMD slides 3.1% to $7.19, a 1-month low, 3 down days in a row
- Closed at $7.19, -3.10% vs the prior close of $7.42. Day range $7.17–$7.45, opened at $7.45.
- Volume was 1.13M shares, 1.0x its 50-day average of 1.11M.
- Price is -8.5% vs its 50-day average ($7.86) and -10.2% vs its 200-day average ($8.00).
- 52-week range $6.13–$13.02; today's close sits at 15% of that range, 44.8% below the 52-week high.
- That makes 3 straight losses.
CRMD bull case vs bear case (from the data)
- Annual revenue grew 617.0% in the latest fiscal year (SEC XBRL).
- Latest fiscal-year net income: profit of $163.06M.
- Price is -4.3% vs its 50-day average — short-term trend is down.
- Price is -3.3% vs its 200-day average — below the long-term trend line.
- Insider selling outweighs buying: 25 sales vs 0 open-market buys among the 25 most recent reported insider trades (Form 4, last 12 months).
CRMD latest news & SEC filings
Every SEC filing by or about CRMD in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 19, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Dillione Janet converted options/RSUs into 48,909 shares on Sep 18, 2026; now holds 117,835
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $101.93M (prior year $39.74M) (+156.5% vs Jun 30, 2025)
- Net income: $25.99M (prior year $19.83M) (+31.1% vs Jun 30, 2025)
- Diluted EPS: $0.29 (prior year $0.28) (+3.6% vs Jun 30, 2025)
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 7, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 4.01 — Changed its outside auditor.
Jun 25, 2026 · Form S-8 POS — S-8 POS filing
S-8 POS filing
Jun 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Things to know before you trade CRMD
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 14, 2026, Mar 5, 2026, Jan 8, 2026. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.27% (largest 3.6%).
- Liquidity: about 991.95K shares (≈$7.43M) trade per day on average.
- 52-week position: $7.49 vs a range of $6.13–$13.02 (20% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Janet Dillione sold 10,000 shares on Jan 21, 2026.
- Latest filings: 8-K Oct 19, 2026; 10-Q Aug 13, 2026; 8-K Aug 13, 2026.
- Share count: 77.94M shares outstanding (Aug 10, 2026), +4.4% vs a year earlier.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
CRMD market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 7.26 | 7.57 | 7.25 | 7.49 | 472.32K |
| Oct 16, 2026 | 7.47 | 7.47 | 7.24 | 7.26 | 1.14M |
| Oct 15, 2026 | 7.49 | 7.70 | 7.43 | 7.46 | 1.47M |
| Oct 14, 2026 | 7.36 | 7.53 | 7.27 | 7.39 | 1.12M |
| Oct 13, 2026 | 7.43 | 7.55 | 7.33 | 7.39 | 1.42M |
| Oct 12, 2026 | 7.41 | 7.60 | 7.16 | 7.46 | 1.59M |
| Oct 9, 2026 | 7.32 | 7.46 | 7.26 | 7.38 | 1.19M |
| Oct 8, 2026 | 7.28 | 7.36 | 7.18 | 7.32 | 1.02M |
| Oct 7, 2026 | 7.27 | 7.31 | 7.18 | 7.28 | 833.00K |
| Oct 6, 2026 | 7.38 | 7.40 | 7.13 | 7.28 | 744.30K |
| Oct 5, 2026 | 7.18 | 7.33 | 7.06 | 7.26 | 1.26M |
| Oct 2, 2026 | 7.45 | 7.45 | 7.17 | 7.19 | 1.13M |
| Oct 1, 2026 | 7.65 | 7.69 | 7.40 | 7.42 | 1.05M |
| Sep 30, 2026 | 7.95 | 7.95 | 7.66 | 7.70 | 948.40K |
| Sep 29, 2026 | 7.91 | 7.96 | 7.82 | 7.93 | 817.40K |
| Sep 28, 2026 | 7.77 | 7.90 | 7.77 | 7.89 | 485.00K |
| Sep 25, 2026 | 7.79 | 7.90 | 7.69 | 7.85 | 606.60K |
| Sep 24, 2026 | 7.70 | 7.79 | 7.62 | 7.77 | 946.50K |
| Sep 23, 2026 | 8.03 | 8.19 | 7.63 | 7.69 | 812.40K |
| Sep 22, 2026 | 7.83 | 7.83 | 7.69 | 7.78 | 788.90K |
About CorMedix
CorMedix (CRMD) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in PARSIPPANY, NJ. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1410098.
CRMD board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Alan W Dunton | Director | Jan 27, 2026 |
| Janet Dillione | Director | Sep 18, 2026 |
| Gregory Scott Duncan | Director | Jan 27, 2026 |
| Myron Kaplan | Director | Jan 27, 2026 |
| Steven W Lefkowitz | Director | Jan 27, 2026 |
| Robert A Stewart | Director | Jan 27, 2026 |
| Joseph Todisco | Chief Executive Officer | Feb 6, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Susan Blum | Chief Financial Officer | Sep 1, 2026 |
| Elizabeth Hurlburt | Chief Operating Officer | Sep 1, 2026 |
| Michael David Seckler | Chief Commercial Officer | Jan 15, 2026 |
| Joseph Todisco | Chief Executive Officer | Feb 6, 2026 |
| Kaufman Beth Zelnick | Chief Legal Officer | Sep 1, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jan 21, 2026 | Janet Dillione | Sale | 10,000 | $6.88 |
| Jan 21, 2026 | Janet Dillione | Sale | 10,000 | $6.88 |
| Jan 21, 2026 | Janet Dillione | Sale | 10,000 | $6.88 |
| Jan 21, 2026 | Janet Dillione | Sale | 10,000 | $6.88 |
| Dec 30, 2025 | Alan W Dunton | Sale | 20,000 | $13.00 |
| Dec 30, 2025 | Alan W Dunton | Sale | 20,000 | $13.00 |
| Dec 30, 2025 | Alan W Dunton | Sale | 20,000 | $13.00 |
| Dec 30, 2025 | Alan W Dunton | Sale | 20,000 | $13.00 |
| Dec 18, 2025 | Joseph Todisco | Sale | 30,000 | $12.00 |
| Dec 18, 2025 | Joseph Todisco | Sale | 30,000 | $12.00 |
| Dec 18, 2025 | Joseph Todisco | Sale | 30,000 | $12.00 |
| Dec 18, 2025 | Joseph Todisco | Sale | 30,000 | $12.00 |
| Dec 9, 2025 | Janet Dillione | Sale | 34,000 | $12.00 |
| Dec 9, 2025 | Janet Dillione | Sale | 34,000 | $12.00 |
| Dec 9, 2025 | Janet Dillione | Sale | 34,000 | $12.00 |
CRMD financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $311.71M | $163.06M | 2.04 | $175.05M |
| Dec 31, 2024 | $43.47M | $-17.93M | -0.30 | $-50.62M |
| Dec 31, 2023 | — | $-46.34M | -0.91 | $-38.41M |
| Dec 31, 2022 | $65.41K | $-29.70M | -0.74 | $-24.36M |
| Dec 31, 2021 | $190.94K | $-28.21M | -0.75 | $-21.16M |
Latest balance sheet: total assets $904.05M, total liabilities $443.22M, cash $256.69M (as of Jun 30, 2026).
CRMD earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $8.14 |
| May 14, 2026 | 8-K Item 2.02 (results) | $7.93 |
| Mar 5, 2026 | 8-K Item 2.02 (results) | $6.30 |
| Jan 8, 2026 | 8-K Item 2.02 (results) | $7.51 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $11.42 |
| Oct 20, 2025 | 8-K Item 2.02 (results) | $12.16 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $10.81 |
| May 6, 2025 | 8-K Item 2.02 (results) | $11.16 |
| Apr 8, 2025 | 8-K Item 2.02 (results) | $6.79 |
| Mar 25, 2025 | 8-K Item 2.02 (results) | $7.34 |
| Jan 7, 2025 | 8-K Item 2.02 (results) | $10.30 |
| Oct 30, 2024 | 8-K Item 2.02 (results) | $10.05 |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)Novo Nordisk A S (NVO)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on CRMD
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: intraday data as of Oct 19, 2026, 12:35 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.